BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.49 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -0.76 (-1.34%)
BOP 35.41 Increased By ▲ 0.29 (0.83%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.15 Increased By ▲ 1.40 (2.47%)
FCSC 5.15 No Change ▼ 0.00 (0%)
FFL 17.90 Increased By ▲ 0.02 (0.11%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.56 Increased By ▲ 0.14 (1.66%)
KOSM 6.75 Increased By ▲ 0.17 (2.58%)
MLCF 105.65 Increased By ▲ 2.35 (2.27%)
NBP 202.10 Increased By ▲ 1.92 (0.96%)
PACE 11.28 Decreased By ▼ -0.01 (-0.09%)
PAEL 44.42 Increased By ▲ 0.95 (2.19%)
PIAHCLA 28.66 Increased By ▲ 1.17 (4.26%)
PIBTL 18.75 Increased By ▲ 1.05 (5.93%)
PPL 248.10 Increased By ▲ 3.78 (1.55%)
PRL 35.35 Decreased By ▼ -0.08 (-0.23%)
PTC 66.15 Increased By ▲ 0.80 (1.22%)
SEARL 94.95 Increased By ▲ 1.63 (1.75%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.93 Increased By ▲ 0.02 (0.22%)
THCCL 66.65 Decreased By ▼ -0.07 (-0.1%)
TPLP 10.76 Decreased By ▼ -0.07 (-0.65%)
TREET 25.22 Increased By ▲ 0.10 (0.4%)
TRG 64.21 Decreased By ▼ -0.69 (-1.06%)
WAVES 10.85 Decreased By ▼ -0.08 (-0.73%)
WTL 1.27 Increased By ▲ 0.02 (1.6%)
World

Cuba to collaborate with Iran on coronavirus vaccine

  • The allies are both under fierce US sanctions that exempt medicine yet often put foreign pharmaceutical companies off trading with them and as such they seek to be self-reliant.
  • Iran launched human trials of its first domestic COVID-19 vaccine candidate late last month, while Cuba has four candidates currently in trials although none yet in humans.
Published January 9, 2021 Updated January 9, 2021 08:30pm
By

HAVANA: Communist-run Cuba said late on Friday it had signed an accord with Iran to transfer the technology for its most advanced coronavirus vaccine candidate and carry out last-stage clinical trials in humans of the shot in the Islamic Republic.

The allies are both under fierce US sanctions that exempt medicine yet often put foreign pharmaceutical companies off trading with them and as such they seek to be self-reliant. Both are also strapped for cash.

Iran launched human trials of its first domestic COVID-19 vaccine candidate late last month, while Cuba has four candidates currently in trials although none yet in humans.

Once its most advanced candidate, Soberana (Sovereign) 2, has completed Phase II trials which started on Dec. 22, it will be tested in human trials in around 150,000 people in Havana, officials have said.

Yet the Caribbean country will need to conduct more human trials abroad too given it does not have a high infection rate due to its successful management of its outbreak, they said. Iran, meanwhile, has been the worst-hit country in the Middle East.

Cuba's Finlay Vaccine Institute said late on Friday it has signed an accord with Iran's Pasteur Institute to collaborate on testing of Soberana 2.

"This synergy will enable both countries to advance more rapidly in the immunization against the SARS-CoV-2 virus," it said on its Twitter account.

Cuba says several countries have expressed interest in its coronavirus vaccines but this is the first such accord it has reached.

Health Ministry spokesman Kianush Jahanpur was cited by Iranian media as saying 50,000 volunteers would be recruited to carry out the Phase III clinical trials. Technology transfer and joint production were preconditions for allowing human testing in the country, he said.

Iran Foreign Minister Javad Zarif said he was "impressed" by the biotech achievements of its old ally Cuba in the fight against COVID-19 during a visit to Havana on a Latin American tour last November.

In addition to developing its own vaccine, Iran is participating in the COVAX scheme which aims to secure fair access to COVID-19 vaccines for poorer countries. Yet its Supreme Leader on Friday banned the government from importing COVID-19 vaccines from the United States and Britain, labeling the Western powers "untrustworthy."

Cuba has not talked of importing vaccines from elsewhere and said it intends to start vaccinating its population against COVID-19 with its own vaccine in the first half of the year.

Comments

Comments are closed for this article.